论文部分内容阅读
目的观察前列安联合哈乐治疗良性前列腺增生(BPH)膀胱逼尿肌受损的临床疗效。方法以尿动力学检查逼尿肌收缩力分级为极弱(VW)和弱减(W-)、弱加(W+)的前列腺增生症患者为主要观察对象,按随机数字表法随机分为2组,治疗组(前列安联合盐酸坦索罗辛缓释胶囊)30例,对照组(盐酸坦索罗辛缓释胶囊)30例,4周为1疗程,观察1疗程。结果治疗组总有效率为83.33%;对照组总有效率为63.33%(P<0.05)。治疗组Ⅰ-PSS评分、膀胱剩余尿量平均减少均明显优于对照组(P<0.05)。结论前列安联合盐酸坦索罗辛缓释胶囊治疗BPH膀胱逼尿肌收缩力受损有较好疗效。
Objective To observe the clinical efficacy of Qianliean combined with Halol in the treatment of bladder detrusor damage in benign prostatic hyperplasia (BPH). Methods The patients with benign prostatic hyperplasia (VW), weakened (W-) and weak plus (W +) were examined with urodynamic examination. The patients were randomly divided into two groups according to random number table 30 patients in the treatment group (Qiananan combined tamsulosin sustained-release capsules) and 30 control group (tamsulosin hydrochloride sustained-release capsules) were treated with 1 course of treatment for 4 weeks. Results The total effective rate was 83.33% in the treatment group and 63.33% in the control group (P <0.05). Treatment group Ⅰ-PSS score, bladder residual urine volume were significantly better than the control group (P <0.05). Conclusion Qianlian combined tamsulosin hydrochloride sustained-release capsules for the treatment of BPH detrusor contractility of the bladder has a good effect.